Blockchain Registration Transaction Record

Cardio Diagnostics Expands Access to Cardiovascular Tests Through Groundbreaking Telehealth Agreement

Cardio Diagnostics Holdings, Inc. partners with Navierre to expand access to AI-enabled precision cardiovascular diagnostic tests, revolutionizing the patient cardiovascular care journey and addressing the critical issue of increasing wait times for specialty care while democratizing access to top-tier heart disease services.

The partnership between Cardio Diagnostics and Navierre is important as it revolutionizes the patient cardiovascular care journey through earlier detection, accessible specialty care, and personalized prevention. This collaboration directly responds to current diagnostic methods' limitations, offering a scalable solution that extends to remote zip codes in the U.S. The shift to digital health and AI-driven diagnostics could have a broad impact on the cardiovascular detection, care, and management industry, offering a response to the goal of combating cardiovascular diseases globally while committing to health equity and access.